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Abstract
Background: The requirement of a large amount of high-quality RNA is a major limiting factor for
microarray experiments using biopsies. An average microarray experiment requires 10–100 µg of
RNA. However, due to their small size, most biopsies do not yield this amount. Several different
approaches for RNA amplification in vitro have been described and applied for microarray studies.
In most of these, systematic analyses of the potential bias introduced by the enzymatic
modifications are lacking.
Results: We examined the sources of error introduced by the T7 RNA polymerase based RNA
amplification method through hybridisation studies on microarrays and performed statistical
analysis of the parameters that need to be evaluated prior to routine laboratory use. The results
demonstrate that amplification of the RNA has no systematic influence on the outcome of the
microarray experiment. Although variations in differential expression between amplified and total
RNA hybridisations can be observed, RNA amplification is reproducible, and there is no evidence
that it introduces a large systematic bias.
Conclusions: Our results underline the utility of the T7 based RNA amplification for use in
microarray experiments provided that all samples under study are equally treated.
Background
The utility of microarrays for disease classification, prog-
nosis and progression, or the identification of target genes
for novel therapeutic approaches is well documented [1-
5] and is likely to change our views of disease develop-
ment [6,7]. The major bottlenecks for these experiments
are the limited availability and low quality of tissue or
RNA. The issue of quality can be easily solved using
appropriate tissue handling techniques. However, solid
tumours are usually too small to yield enough RNA for
direct use in microarray experiments. Therefore, amplifi-
cation techniques have to be applied to increase the
amount of available RNA and minimise the required start-
ing material. Two basically different approaches for RNA
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amplification have been used by various laboratories: In
the first, the polymerase chain reaction (PCR) is per-
formed to increase the amount of sample either exponen-
tially [8,9] or linearly [10]. The second approach applies
in vitro transcription with T7 RNA polymerase [11-14] for
linear amplification of the sample. Both approaches differ
in the lengths of the double-stranded cDNA molecules
generated in the reverse transcription process prior to
amplification. Since enzymatic modifications on a highly
complex mixture of RNA/cDNA molecules are performed
during the reaction, it can be presumed that noise and sys-
tematic biases are introduced. Thus, it is essential to quan-
tify the effect of amplification and examine the
reproducibility of the method.
To study genetic changes during breast cancer, we have
developed a cDNA microarray consisting of 7,347 genes
and expressed sequence tags (ESTs). We have established
a robust method to amplify total RNA via a T7 RNA
polymerase based process [11] and used this method for
the amplification of RNA from different tissues and
hybridised the corresponding labeled cDNA products on
cDNA microarrays. Our goals were to assess the reproduc-
ibility of the amplifications, compare the results between
unamplified and amplified RNA (aRNA), and quantify
the bias introduced to the data by the RNA amplification
process.
Results
Amplification factors
We used the linear amplification technique of van Gelder
et al. [11] which is based on a double-stranded cDNA syn-
thesis with an oligo-dT primer coupled to the T7 RNA
polymerase promoter and subsequent in vitro transcrip-
tion into aRNA using T7 RNA polymerase. In 30 separate
reactions, we achieved amplification factors of 150–560
when 100–3,200 ng of total RNA was used as starting
material (table 1). The amplification of no more than
100–200 ng of total RNA (14 reactions) resulted in a 368
fold average increase of poly (A)+  RNA equivalents
whereas the amplification of 1,000–3,200 ng (16 reac-
tions) resulted in an average amplification factor of 253.
All amplification factors were calculated according to the
assumption that 5% of total RNA correspond to poly (A)+
RNA. The quality of all total and amplified RNA was
checked using the Agilent 2100 Bioanalyzer. Only high-
quality RNA was used for amplification because low-qual-
ity RNA can influence the outcome of amplification. The
measurement of the amplified RNA showed a length
reduction of the first-round amplified RNA compared to
the total RNA (not shown). The sizes of the amplified
RNA molecules were distributed between 100 and 4,500
bases. In total, 69 microarray hybridisations were used for
the analysis of the different parameters and were per-
formed as summarised in tables 2 and 3. All microarrays
used in these experiments were taken from two spotting
runs in which a total of 200 arrays had been produced.
Comparability of data sets obtained from amplified and 
non-amplified RNA
In 49 hybridisation experiments (tables 2 and 3), we com-
pared the generalised log ratios of 7,347 genes using
amplified or total RNA for labelling (figure 1). When
labelled samples derived from total (Cy-3) vs. total (Cy-5)
RNA were hybridised on 10 different microarrays, the
boxplots, indicating the variation of the generalised log
ratios, were generally wider in comparison to those of a
second set of 10 microarrays with samples derived from
amplified (Cy-3) vs. amplified (Cy-5) RNA (figure 1A).
This result holds for the cases where differential expres-
sion is not expected (figure 1A, Ta and Tb compared to Aa
and Ab) due to the use of the same tissue source for RNA
isolation or whether it is anticipated (figure 1A, Tc and Td
compared to Ac and Ad) since different tissues were used.
These findings indicate a considerably lower variability of
generalised log ratios of aRNA vs. aRNA hybridisations
compared to total vs. total RNA hybridisations.
In a second experiment (figure 1B), we hybridised total
RNA against aRNA from the same tissue samples on 15
microarrays. The result (figure 1B, group A) shows that the
degree of variation of generalised log ratios is even larger
than in the case of the total vs. total RNA hybridisation
(figure 1A). Although no differentially expressed gene is
expected in these experiments, the high variation of the
generalised log ratios indicates decreased sensitivity of the
measurement if total RNA is compared to aRNA on the
same array. Therefore, different types of RNA (amplified
and total RNA) should not be compared within one exper-
iment. In contrast, only small variations were observed for
the generalised log ratios of the corresponding 14 micro-
array hybridisations with aRNA vs. aRNA (figure 1B,
groups B and C). In summary, the variability of the gener-
alised log ratios of the 49 microarray hybridisations
decreased from (1) total vs. aRNA, (2) total vs. total RNA
to (3) aRNA vs. aRNA.
Linearity of amplification reactions
Prior to performing large scale microarray gene expression
studies using RNA amplification, it is important to
address the question as to whether the enzymatic modifi-
cation of the RNA introduces a systematic bias to the list
of differentially expressed genes. In other words: Is the
amplification "linear"? To approach this problem, we
hybridised 20 microarrays with samples derived from
either total vs. total RNA or aRNA vs. aRNA from the same
sources (table 2). The arithmetic mean of the resulting val-
ues from all hybridisations was determined for each gene
and each channel separately (figure 2, Cy-3 channel not
shown). In the ideal situation (100% correlation, identityBMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/29
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line), the overall correlation coefficient should be equal to
1. The scattering of values around the identity line reflects
the influences of gene specific RNA amplification factors
and noise. For both channels, the scattering of values is
homogeneously distributed on both sides of the identity
line, which indicates an overall linear amplification. The
correlation coefficients between total and aRNA calcu-
lated from the experiments were 0.87 and 0.89 for the
individual Cy-5 and Cy-3 channels, respectively. Thus,
there is a clear correlation between signal intensities
resulting from non-amplified RNA as compared to ampli-
fied RNA, suggesting that aRNA hybridisations corre-
spond to those obtained with unmodified samples.
Reproducibility of RNA amplification
Several other groups [8,10,14,15] have applied Pearson
correlation coefficients between log ratios in order to
show the reproducibility of the RNA amplifications. High
correlation coefficients are 0.8 or greater. We performed
pairwise calculations of correlation coefficients using six
hybridisations with aRNA samples (table 2, correlation).
In result, the coefficients varied from 0.95 to 0.99 indicat-
ing a very high correlation between the individual ampli-
fication reactions.
A statistically solid way to estimate the reproducibility of
hybridisations is the F statistic in which the ratio of vari-
ances between the different amplification groups is com-
pared to that within the amplification groups. When the
between variation is almost the same as the within varia-
tion, the logarithmic F-value comes to lie around zero,
indicating high reproducibility; when the variation
between is larger or smaller than within hybridisations, the
F-value becomes larger or smaller than zero, respectively.
To estimate the ratios, we performed four amplification
reactions from the same total RNA source. The labelled
products were hybridised in triplicate against an amplified
reference sample on 12 microarrays (table 2, reproducibil-
ity). These experiments were carried out on two different
days (table 2; day 1, arrays 58–61; day 2, arrays 62–69).
Table 1: Amplification factors
tot RNA starting 
amount [ng]
Repetitions Range of amplified 
RNA [µg]
Average amount of 
amplified RNA [µg]
Range of 
amplification 
factors
Average 
amplification 
factor*
100–200 14 1–4.4 2.49 200–560 368
1,000–3,200 16 12–36 22 150–500 253
* calculated under the assumption that 5% of total RNA corresponds to poly (A)+ RNA
Table 2: Microarray hybridisations used for the data analysis
Parameter Figure Microarrays used Total Nr. of arrays Normalisation group
Comparability 1a Ta: 1,2 10 α
Tb: 3,4
Tc: 5–7
Td: 8–10
Aa: 11,12 10
Ab: 13,14
Ac: 15–17
Ad: 18–20
1b A: 21–35 29 β
B: 36–43
C: 44–49
Linearity 2a 5–7,50–53 (Cy5) 14 γ
15–17,54–57 (Cy5)
- 5–10 (Cy3) 12 δ
15–20 (Cy3)
Correlation -4 4 – 4 9 6ε
Reproducibility 3 58–69 12 ζ
Correspondence 45 0 – 5 7 8ηBMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/29
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For each gene from these hybridisations, an F-value was
calculated and plotted in a histogram (figure 3). The neg-
ative median log F-value (-0.66) indicated a higher vari-
ance within than between the amplification groups. When
only hybridisations performed on day 2 were considered,
a median log F of 0.20 was found. These results suggest
that other sources of variation (e.g. day-to-day variation,
labelling, chip-batches) are of greater influence on the
total variation of microarray hybridisations rather than
the RNA amplification itself.
Correspondence of gene expression data obtained with 
amplified and total RNA
For the biological interpretation of the data, the crucial
question concerning the use of RNA amplification meth-
ods is: Which proportion of the differentially expressed
genes identified by hybridisation of total vs. total RNA
corresponds to those found by hybridisation of aRNA vs.
aRNA? To examine this question, we used eight microar-
ray hybridisations (table 2), four of which were per-
formed using total RNA vs. total RNA from different
tissues, the other four with aRNA vs. aRNA derived from
these total RNA samples. The generalised log ratios of four
hybridisations were averaged and plotted against each
other. For the highest 2,000 out of 7,347 genes, the corre-
lation coefficient was 0.85 (figure 4). When low intensity
genes were included, the correlation dropped to 0.72 (not
shown), owing to the lower signal to noise ratios for these
genes. The distribution of generalised log ratios in the
aRNA hybridisations appears to be compressed (slope of
0.54 for the regression line), indicating a decreased sensi-
tivity of the aRNA results compared to total RNA hybridi-
sation data. Within the group of 2,000 highest expressed
genes we also looked in each case, total RNA and aRNA
experiments, at the 500 highest differentially expressed
genes. The minimum fold change was 2.6 for total RNA
and 1.8 for amplified RNA experiments. Out of 344 com-
mon genes (69%) all showed the same direction of
regulation.
Discussion
In vitro transcription of cDNA for the amplification of
RNA is a commonly used method that requires low
amounts of input total RNA, typically less than 1 µg, often
as little as 100 ng. This amount can be reliably reduced
further to the level of RNA from a few hundred cells when
microdissected tissue is used for RNA isolation. Thus, the
method is an absolute prerequisite for gene expression
Table 3: Experimental design of microarray hybridizations
Array Nr. Cy3 RNA 
source*
Cy5 RNA 
source*
Array Nr. Cy3 RNA 
source*
Cy5 RNA 
source*
Array Nr. Cy3 RNA 
source*
Cy5 RNA 
source*
1 ba24 aA 2 47 B1 B2
2 ba25 bB 1 48 B1 B3
3 cb26 bB 1 49 B1 B4
4 cb27 bB 2 50 dp l a
5 ref2 pla 28 bB 2 51 dp l a
6 ref2 pla 29 aA 3 52 dp l a
7 ref2 pla 30 aA 3 53 dp l a
8 ref2 d 31 aA 4 54 DP L A
9 ref2 d 32 bB 3 55 DP L A
10 ref2 d 33 bB 3 56 DP L A
11 B1 A1 34 bB 4 57 DP L A
12 B1 A1 35 bB 4 58 REF1 A1
13 C4 B4 36 A1 A1 59 REF1 A2
14 C4 B4 37 A2 A2 60 REF1 A3
15 REF2 PLA 38 A3 A3 61 REF1 A4
16 REF2 PLA 39 A4 A4 62 REF1 A1
17 REF2 PLA 40 B1 B1 63 REF1 A1
18 REF2 D 41 B2 B2 64 REF1 A2
19 REF2 D 42 B3 B3 65 REF1 A2
20 REF2 D 43 B4 B4 66 REF1 A3
21 aA 1 44 A1 A2 67 REF1 A3
22 aA 1 45 A1 A3 68 REF1 A4
23 aA 2 46 A1 A4 69 REF1 A4
* lowercase letters: total RNA; capital letters: amplified RNA. A, a, B, b, C, c: RNA from human (untreated) mcf7 cell tumours induced in different 
SCID mice; D, d: adriamycin-treated mcf7 cell tumours grown in a SCID mouse. PLA, pla: human placenta; REF1, ref1, REF2, ref2: different pools of 
a, b and c.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/29
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microarray experiments in which the amount of sample is
the major limiting factor. We have obtained average
amplification factors of more than 350 poly (A)+ equiva-
lents in a single amplification round. With these values,
the amount of aRNA derived from 1 µg total RNA is suffi-
cient to perform at least eight microarray hybridisations
with 2 µg aRNA each. The benefit is twofold: First, it is
possible to perform multiple experiments with minute
amounts of sample and perform a statistical analysis of
the data. Second, additional data validation experiments
(e.g. quantitative RT-PCR) can be performed using the
same physical sample. These benefits will further increase
in the future when array based diagnostics become
available.
Despite the obvious advantages of the amplification
method, systematic analyses of the impact of this enzy-
matic modification on the microarray gene expression
results are scarce. From the analysis of the variability of
the results, we conclude that it is vital to use equally
treated samples for any particular experiment: If one sam-
ple requires amplification, all other samples should be
amplified as well. Comparison of data from amplified
and non-amplified RNA results in the widest log ratio dis-
tribution of all combinations of aRNA and total RNA
Comparison of generalised log ratios in hybridisations on 7,347-gene microarrays Figure 1
Comparison of generalised log ratios in hybridisations on 7,347-gene microarrays Each boxplot (x-axis) character-
ises the distribution of the generalised log ratios (y-axis) of A) total RNA vs. total RNA and aRNA vs. aRNA from the same 
origin (duplicate hybridisations of Ta, Tb and Aa, Ab, respectively) and from different tissue sources (triplicate hybridisations of 
Tc, Td and Ac, Ad, respectively) and B) 15 microarray hybridisations from the same tissue sources using total RNA vs. aRNA 
(A) and 14 hybridisations using aRNA vs. aRNA (B and C).BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/29
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samples. This may lead to the identification of too many
false positive differentially expressed genes. The opposite
effect was seen when amplified vs. amplified RNA was
used: The log ratio plots are slimmer when compared to
total vs. total RNA hybridisations. Although this leads to
a loss of sensitivity of the experiment, the criteria for the
identification of differentially expressed genes are more
stringent when aRNA rather than total RNA samples are
used. RNA amplification does not introduce a systematic
bias to the gene expression data: Microarray hybridisation
results obtained with aRNA are comparable with those
from total RNA. The relationship is linear over the whole
dynamic range. Despite the linearity for most genes, how-
ever, one should consider the possibility that, due to
sequence or structure-specific properties, a minority of
genes have gene-specific amplification factors different to
the rest. We cannot exclude the existence of such genes;
however, we are not aware of a systematic study that has
addressed this question down to the level of individual
genes.
RNA amplification reactions are very reproducible. We
found high correlation coefficients between repeated
microarray hybridisations indicating that there is no
major bias due to the amplification reaction that affects
the results obtained from separate amplification reac-
tions. Thus, in the light of all other well known technolog-
ically caused sources of error in microarray experiments
which have to be considered carefully when the experi-
ments are designed, the error introduced by RNA amplifi-
cation is small. The differentially expressed genes
identified by hybridisation of aRNA vs. aRNA correspond
well with those found by hybridisation of total RNA. For
the differentially expressed genes with the 27% highest
signal intensities, the correlation coefficient was 0.85.
Conclusions
We showed that the use of the T7 RNA polymerase based
amplification prior to microarray experiments is well-
grounded because no systematic bias is introduced.
Although variations in differential expression between
amplified and total RNA hybridisations can be observed,
the amplifications are reproducible, and the results of
aRNA correspond to those obtained with total RNA. The
slightly lower sensitivity of aRNA to detect differential
gene expression can be compensated by the use of
additional technical improvements or biological repeti-
tions coupled to statistical data analysis.
Correlation of normalised signal intensities Figure 2
Correlation of normalised signal intensities Averaged 
vsn-normalised signal intensities [quanta] of unamplified sam-
ples (x-axis) were compared to amplified ones (y-axis) for 
the Cy-5 channel. Fourteen microarray hybridisations were 
used (for details, see tables 2 and 3). A symmetric scatter 
around the identity line indicates an overall linear amplifica-
tion. Similar results were obtained for the Cy-3 channel.
Reproducibility of RNA amplifications Figure 3
Reproducibility of RNA amplifications The distribution 
(frequency, y-axis) is plotted against the gene specific log F 
values (x-axis). aRNA samples from four distinct amplification 
reactions were used in 12 separate microarray 
hybridisations.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/29
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Methods
Tissue samples and RNA isolation
Tissue samples: Intraperitoneal injection of the human
breast cancer cell line mcf7 into severe combined immun-
odeficiency (SCID) mice resulted in the growth of a solid
tumour mass [16-18] varying in diameter from 1 to 7 mm.
Six to nine weeks post injection, mice were sacrificed by
application of CO2, and the tumour mass was
immediately frozen in liquid nitrogen. Human placental
tissue was frozen as soon as possible. Total cellular RNA
was isolated with the Trizol-method (TriFast, peqlab,
Erlangen, Germany), following the manufacturers instruc-
tions, after homogenisation with a Mikro-Dismembrator
S (Braun Biotech, Melsungen, Germany). The quality of
the RNA samples was checked by the Agilent 2100 bioan-
alyzer (Agilent Technologies, Waldbronn, Germany).
Only high-quality RNA samples (ratio 28S/18S rRNA >
1.8) were selected for the experiments.
RNA amplification
The cDNA synthesis was performed using a cDNA Synthe-
sis System Kit (Roche Diagnostics, Mannheim, Germany)
according to the manufacturers instructions. The ds cDNA
was purified by phenol/chloroform extraction [19] pre-
cipitated in 5 M NH4OAc [19] and resuspended in 8 µl
RNase-free water.
In vitro transcription [11] was performed using the
AmpliScribeTM T7 High Yield Transcription Kit
(Epicentre Technologies, Madison, WI, USA) according to
the manufacturers instructions with the exception of
increasing the incubation time to 4 hours. The newly syn-
thesized aRNA was extracted in phenol/chloroform/iso-
amylalcohol as described above. Unincorporated dNTPs
were removed by chromatography with MobiSpin S-300
columns (MoBiTec GmbH, Göttingen, Germany). Etha-
nol precipitation was performed as described in [19] and
the resulting pellet was resuspended in 20–50 µl RNase-
free water.
Microarray spotting
Glass slides used for this study carried 7,347 breast spe-
cific cDNA clones selected from the Human UniGene 1
clone set (German Resource Centre for Genome Research,
Berlin, Germany). The clones were amplified by PCR and
spotted in a "replicate array" design on silane-prep™ slides
(Sigma Diagnostics, St. Louis, USA) to produce 14,694
individual spots. The slides were rehydrated, and the DNA
was denatured with boiling water treatment prior to wash-
ing with 0.2% SDS, MilliQ- H2O, 95% and 100% Ethanol.
After the washing procedure, the microarrays were dried
with compressed air.
RNA labelling and hybridisation
2 µg amplified antisense RNA (aRNA) were mixed with
500 ng random hexamer primers, incubated at 70°C for
10 min and cooled on ice. Alternatively, 10 µg total RNA
were mixed with 500 ng (dT)17 primer, incubated at 70°C
for 10 min and cooled on ice. The labelling reaction was
performed in a 12.5 µl reaction volume using 2.5 µl 5x RT
buffer (Invitrogen, Karlsruhe, Germany), 1.25 µl 0.1 M
DTT (Invitrogen), 1 µl dNTP-mix (dGAT, 5 mM each), 0.5
µl dCTP (3 mM), 0.5 µl RNasin (40 U/µl), 0.5 µl Cy-3 or
Cy-5 labelled dCTP (1 mM, Amersham Biosciences,
Freiburg, Germany) and 1 µl Superscript II reverse tran-
scriptase (100 U/µl, Invitrogen). The mixture was incu-
bated for 1 h at 42°C, and the reaction was stopped by
addition of 1.25 µl 50 mM EDTA (pH 8). The input RNA
was removed by hydrolysis with 5 µl 1 M NaOH at 65°C
for 10 min, followed by neutralisation with 1 µl 5 M acetic
acid. Cy-3 and Cy-5 labelled probes were combined, pre-
cipitated with isopropanol, washed with 70% ethanol, air
dried and resuspended in 30 µl hybridisation buffer. The
hybridisation buffer consisted of 350 µl 2x DIG-EASY
(Roche Diagnostics), 210 µl MilliQ-H2O, 70 µl 50x Den-
hardt's solution [19] and 70 µl Cot1-DNA (10 ng/µl). The
30 µl probe was heat denatured at 65°C for 2 min and
hybridised to cDNA glass microarrays in a hybridisation
chamber (Corning Inc., Acton, USA) over night at 37°C.
Correspondence of gene expression data between amplified  and non-amplified samples Figure 4
Correspondence of gene expression data between 
amplified and non-amplified samples The averaged gen-
eralised log ratios of the total RNA hybridisations (x-axis) 
are plotted against those of the aRNA hybridisations (y-axis). 
Only the 2,000 highest intensity genes were considered.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/29
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After hybridisation the microarrays were washed at 25°C
in a water bath with 1x SSC containing 0.1% SDS once for
15 min, and twice for 10 min. This was followed by wash-
ing twice with 0.1x SSC containing 0.1% SDS for 10 min.
Washing steps were completed in 70% and 95% ethanol
before the microarrays were dried.
Image quantification
The hybridised arrays were scanned with the GenePix
4000 B microarray scanner (Axon Instruments Inc., Union
City, CA, USA), and the scanned images were analysed
using GenePix Pro 4.0 software (Axon Instruments). Spot
intensities were obtained by subtracting the median
brightness of a region around the spot from the median of
the region within.
Data analysis
For each of the datasets α ... η (table 2), the spot intensi-
ties were calibrated and transformed by the VSN method
[20]. Differences between the resulting values are referred
to as "generalised log ratios". All 14.694 spots from each
slide were analysed, without filtering or thresholding
procedures.
The reproducibility of different amplification reactions
was measured using the F statistic to compare the variance
for each gene within and between groups of hybridisations
using amplified samples. The F value is defined as the
ratio of the between and within groups mean squares mSSB
and mSSW, whereas the mean square is defined as the sum
of squares divided by the degrees of freedom:
given   and  ,
where yikl denotes the measured value of the lth repetition
of the kth amplification reaction for RNA transcript i. K
denotes the number of all amplification reactions and Lk
the number of replicas in group k.
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